Test Drive 
, our AI Chatbot - get instant regulatory answers, free and live! Try Now
April 2026The EU Scientific Committee on Consumer Safety (SCCS) has issued updated guidance on Butylated Hydroxyanisole (BHA), assessing its safety in cosmetic products.
As of 16 April 2026, BHA is considered safe for use up to 0.07% concentration, though further evaluation is required for endocrine-disrupting potential and environmental impact.
BHA is widely used as an antioxidant in cosmetics and other industries, but scientific reviews highlight the need for continued monitoring due to possible health risks.
The assessment includes detailed analysis of chemical properties, toxicity (including carcinogenicity and genotoxicity), and dermal absorption, with studies showing limited skin penetration but some data gaps.
The SCCS emphasizes the importance of comprehensive safety evaluations, especially given differences in how BHA behaves across species.
This update reflects evolving EU regulatory standards and supports safe use of cosmetic ingredients while ensuring consumer protection.
Region: EU
Source: https://health.ec.europa.eu/latest-updates/sccs-scientific-advice-butylated-hydroxyanisole-bha-2026-04-16_en
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert
